ANKET
Live / Registered — Registered (as of 17 Jan 2023)
What this means for you
Registered since 17 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97085429
- Registration number
- 6952905
- Mark type
- Stylized text
- Filed
- 21 Oct 2021
- Published for opposition
- 01 Nov 2022
- Registered
- 17 Jan 2023
- Attorney of record
- Corey K. Cho
Goods and services
- Class 001 — Chemicals: Chemical or biotechnological products for industry and science, namely, polypeptides and proteins; biological preparations, in particular antibodies in the nature of monoclonal antibodies, bispecific antibodies or multifunctional antibodies, antibody derivatives in the nature of antibody fragments, single-chain variable fragments, di-scFv, light and heavy chains of antibodies, binding proteins and peptides having a binding affinity to immune cells in the nature of T-cell engagers or NK-cell engagers, for laboratory and experimental purposes, in particular for conducting experimental tests other than for medical use; Biochemicals, namely, polypeptides for in vitro research use
- Class 005 — Pharmaceuticals: Pharmaceuticals, medical, biological or biochemical preparations, substances for the treatment of diseases, as well as preparations for medical treatments, in particular, antibodies and derivatives being monoclonal antibodies, bispecific antibodies, multispecific antibodies, antibody fragments, single-chain variable fragments, di-scFv or light and heavy chains of antibodies for medical purposes, bifunctional or multifunctional proteins being T-cell engagers or NK cell engagers for medical purposes with binding affinity to immune cells, in particular NK cells, and other reagents for the diagnosis, prevention, monitoring and treatment of diseases, in particular cancers, infectious diseases, inflammatory diseases, and other immune pathologies
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and development in scientific and medical matters, in particular in the field of immunotherapy; scientific and technological services, namely, scientific research and development related to diagnostic products; pharmaceutical and biotechnological scientific laboratory services; laboratory research, analysis, evaluation, development and clinical trial of therapeutic compositions and treatments in the field of oncology; all of the above services concerning the use of antibodies, antibody derivatives, proteins, or other agents for activating or modulating natural and adaptive immunity
Owner
- INNATE PHARMA, MARSEILLE, FR
- INNATE PHARMA, MARSEILLE, FR
- INNATE PHARMA, MARSEILLE, FR
Prosecution history
- 17 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 01 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Nov 2022 — PUBLISHED FOR OPPOSITION
- 12 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Sept 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Sept 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Sept 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Aug 2022 — NON-FINAL ACTION E-MAILED
- 08 Aug 2022 — NON-FINAL ACTION WRITTEN
- 28 Jul 2022 — ASSIGNED TO EXAMINER
- 07 Nov 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Oct 2021 — NEW APPLICATION ENTERED